Background. The efficacy of extending the application of selective nec
k dissection to include more-extensive neck disease in patients with s
quamous carcinoma of the upper aerodigestive tract remains controversi
al. Methods. A review of all patients undergoing selective neck dissec
tion at a single institution during a 5-year period was undertaken, Th
e analysis was conducted on 82 patients who received 94 selective neck
dissections as part of initial therapy far management of squamous car
cinoma of the upper aerodigestive tract, including: oral cavity, oroph
arynx: larynx, and hypopharynx. Results. Forty-six of the 94 dissected
necks were supraomohyoid dissections, and 48 were lateral neck dissec
tions. Sixty-live percent of patients were followed a minimum of 2 yea
rs and formed the cohort for final analysis. There were eight regional
recurrences, three of which occurred in the contralateral, undissecte
d neck. The regional recurrence rate for all patients undergoing selec
tive neck dissection, with or without radiotherapy, according to patho
logic N status was as follows: NO (1133), 3%; N1 (1/8), 12.5%; and mul
tiple positive nodes (3/26), 11.5%. A comparison of recurrence rates w
ith respect to extent of neck disease (N0-N1 versus multiple positive
nodes) for both types of neck dissection did not demonstrate significa
nt differences; supraomohyoid neck dissection, p < .5; lateral neck di
ssection, p < .25. Conclusions. There exists an expanded role for sele
ctive neck dissection in selected patients with primary squamous cell
carcinoma of the upper aerodigestive tract and multiple N+ cervical di
sease. The selection of patients who are candidates for selective lymp
hadenectomy should be based on pathoanaiomic considerations with refer
ence to the primary site of tumor and 00demonstrated level(s) of metas
tatic involvement. (C) 1997 John Wiley & Sons, Inc.